HCP (NYSE: HCP) reported Q4 FFO of $0.80, $0.02 better than the analyst estimate of $0.78.

GUIDANCE:

HCP sees FY2016 FFO of $2.74-$2.80, versus the consensus of $3.14.

For earnings history and earnings-related data on HCP (HCP) click here.